Cytotheryx, a growing Rochester biotech firm working on treatments for liver disease, recently received $60 million in ...

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...

A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together ...

Researchers from the Cancer Research UK Scotland Institute in Glasgow have discovered why certain cancer-causing genes ...

NEW YORK and SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- Ouroboros Family Founders Fund I, LP announced this week it will lead a $60 million Series A financing in Cytotheryx, Inc., a preclinical cell ...

Learn how weight loss, diet changes and regular exercise can help manage — and sometimes reverse — fatty liver disease when ...

Cytotheryx, a preclinical cell therapy company developing treatments for liver disease, is receiving $60 million in Series A ...

Liver cancer, primarily hepatocellular carcinoma, originates in the liver, with hepatitis B and C as major risk factors. Diagnosis involves physical exams, blood tests, imaging, and possibly biopsy to ...

Dr. Anjana Pillai says treatment depends on stage and health, with surgery, transplant, local therapy or systemic drugs to help people live longer. Dr. Anjana Pillai explains, in an interview with ...

Explore the rising concern of MASLD in India, emphasizing the need for proactive screening and lifestyle changes for ...

Gurugram resident Sarvesh Singh found relief from pre-diabetes and fatty liver disease through a holistic approach at ...

Sleep apnea may worsen fatty liver disease, now called metabolic dysfunction-associated steatotic liver disease (MASLD), by lowering oxygen levels at night. This can trigger chronic inflammation and ...